Evidence map›Paper›PMID 30324489›Full record

ArticleDiabetologia2018

Correction to: Mitochondrial H

Laura Formentini, Alexander J Ryan, Manuel Gálvez-Santisteban, Leslie Carter, Pam Taub, John D Lapek, David J Gonzalez, Francisco Villarreal, Theodore P Ciaraldi, José M Cuezva and 1 more

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Diabetologia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Laura FormentiniVA San Diego Healthcare System, San Diego, CA, USA. lformentini@cbm.csic.es.
Alexander J RyanVA San Diego Healthcare System, San Diego, CA, USA.
Manuel Gálvez-SantistebanDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.
Leslie CarterVA San Diego Healthcare System, San Diego, CA, USA.
Pam TaubVA San Diego Healthcare System, San Diego, CA, USA.
John D LapekDepartment of Pharmacology and Pharmacy, University of California, San Diego, La Jolla, CA, USA.
David J GonzalezDepartment of Pharmacology and Pharmacy, University of California, San Diego, La Jolla, CA, USA.
Francisco VillarrealDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.
Theodore P CiaraldiVA San Diego Healthcare System, San Diego, CA, USA.
José M CuezvaDepartamento de Biología Molecular, CIBER Enfermedades Raras, Centro de Biología Molecular 'Severo Ochoa' (CBMSO), c/ Nicolás Cabrera 1, Universidad Autónoma de Madrid, 28049, Madrid, Spain.
Robert R HenryVA San Diego Healthcare System, San Diego, CA, USA.
University of California, San Diego · USVA San Diego Healthcare System · USUniversidad Autónoma de Madrid · ESUniversity of Manchester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Owing to an oversight, the authors omitted to note that Dr Taub is a co-founder of and equity holder in Cardero Therapeutics.

Identifiers

PMID30324489
OpenAlexW2896644645

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.